Profund Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,622
| Closed | -$597K | – | 1474 |
|
|
2021
Q2 | $597K | Sell |
3,622
-11,225
| -76% | -$1.87M | 0.02% | 567 |
|
|
2021
Q1 | $2.28M | Sell |
14,847
-3,069
| -17% | -$417K | 0.09% | 187 |
|
|
2020
Q4 | $2.25M | Buy |
17,916
+1,354
| +8% | +$151K | 0.1% | 180 |
|
|
2020
Q3 | $1.68M | Sell |
16,562
-193
| -1% | -$19.7K | 0.09% | 198 |
|
|
2020
Q2 | $1.63M | Buy |
16,755
+2,686
| +19% | +$250K | 0.09% | 194 |
|
|
2020
Q1 | $1.17M | Sell |
14,069
-6,306
| -31% | -$615K | 0.09% | 209 |
|
|
2019
Q4 | $2.27M | Buy |
20,375
+1,631
| +9% | +$168K | 0.1% | 182 |
|
|
2019
Q3 | $1.86M | Sell |
18,744
-1,244
| -6% | -$124K | 0.09% | 201 |
|
|
2019
Q2 | $1.98M | Sell |
19,988
-1,977
| -9% | -$189K | 0.09% | 200 |
|
|
2019
Q1 | $2.42M | Buy |
21,965
+2,437
| +12% | +$255K | 0.12% | 160 |
|
|
2018
Q4 | $1.8M | Sell |
19,528
-6,540
| -25% | -$662K | 0.11% | 172 |
|
|
2018
Q3 | $2.87M | Buy |
26,068
+3,794
| +17% | +$395K | 0.11% | 162 |
|
|
2018
Q2 | $2.08M | Buy |
22,274
+4,397
| +25% | +$379K | 0.08% | 197 |
|
|
2018
Q1 | $1.48M | Sell |
17,877
-1,794
| -9% | -$159K | 0.06% | 283 |
|
|
2017
Q4 | $1.79M | Sell |
19,671
-1,959
| -9% | -$163K | 0.07% | 268 |
|
|
2017
Q3 | $1.65M | Buy |
+21,630
| New | +$1.63M | 0.07% | 264 |
|
Other funds holding PRAH
Profund Advisors's PRAH Position: Q3 2021 in Review
Profund Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 3,622 shares — an estimated $597K sold.
Profund Advisors first reported a position in PRAH in Q3 2017 and held it in 16 quarters. The position peaked at $2.87M in Q3 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Profund Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Profund Advisors sold 3,622 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $597K.
- Profund Advisors first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 16 quarters.
- Profund Advisors's PRA Health Sciences, Inc. position peaked at $2.87M in Q3 2018.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Profund Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.